BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35839409)

  • 1. Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
    Zheng J; Pulvirenti A; Javed AA; Michelakos T; Paniccia A; Lee KK; Ferrone CR; Wei AC; He J; Zureikat AH;
    J Am Coll Surg; 2022 Aug; 235(2):315-330. PubMed ID: 35839409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
    Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
    Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method.
    Hwang HK; Song KB; Park M; Kwon W; Jang JY; Heo JS; Choi DW; Kang CM; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ; Hwang DW; Kim SC; Han HS; Yoon YS;
    Ann Surg Oncol; 2021 Nov; 28(12):7742-7758. PubMed ID: 33969463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.
    Alfieri S; Butturini G; Boggi U; Pietrabissa A; Morelli L; Vistoli F; Damoli I; Peri A; Fiorillo C; Pugliese L; Ramera M; De Lio N; Di Franco G; Esposito A; Landoni L; Rosa F; Menghi R; Doglietto GB; Quero G;
    Langenbecks Arch Surg; 2019 Jun; 404(4):459-468. PubMed ID: 31055639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
    Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
    Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lending a hand for laparoscopic distal pancreatectomy: the optimal approach?
    Gamboa AC; Aveson VG; Zaidi MY; Lee RM; Jarnagin WR; Allen PJ; Drebin JA; Peter Kingham T; DeMatteo RP; Sarmiento JM; Russell MC; Cardona K; Kooby DA; D'Angelica MI; Maithel SK
    HPB (Oxford); 2020 May; 22(5):690-701. PubMed ID: 31601508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?
    Zhang J; Jin J; Chen S; Gu J; Zhu Y; Qin K; Zhan Q; Cheng D; Chen H; Deng X; Shen B; Peng C
    Oncotarget; 2017 May; 8(20):33872-33883. PubMed ID: 28477012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.
    Lopez CL; Albers MB; Bollmann C; Manoharan J; Waldmann J; Fendrich V; Bartsch DK
    World J Surg; 2016 Jul; 40(7):1729-36. PubMed ID: 26956903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Perioperative Outcomes between Open, Laparoscopic, and Robotic Distal Pancreatectomy: an Analysis of 1815 Patients from the ACS-NSQIP Procedure-Targeted Pancreatectomy Database.
    Xourafas D; Ashley SW; Clancy TE
    J Gastrointest Surg; 2017 Sep; 21(9):1442-1452. PubMed ID: 28573358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
    Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
    Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting.
    Partelli S; Andreasi V; Rancoita PMV; Perez-Sanchez E; Muffatti F; Balzano G; Crippa S; Di Serio C; Falconi M
    Surg Endosc; 2021 Jan; 35(1):165-173. PubMed ID: 31953734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma.
    Chopra A; Nassour I; Zureikat A; Paniccia A
    Updates Surg; 2021 Jun; 73(3):947-953. PubMed ID: 33394353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours.
    Ferraro V; Tedeschi M; Laera L; Ammendola M; Riccelli U; Silvestris N; Fiorentino A; Surico G; Inchingolo R; Decembrino F; de Angelis N; Memeo R
    Curr Treat Options Oncol; 2021 Feb; 22(4):27. PubMed ID: 33641016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
    Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
    Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
    Fernández-Cruz L; Blanco L; Cosa R; Rendón H
    World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group.
    Zhang XF; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Schmidt CR; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Aug; 120(2):231-240. PubMed ID: 31001868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes.
    Lee SH; Kang CM; Hwang HK; Choi SH; Lee WJ; Chi HS
    Surg Endosc; 2014 Oct; 28(10):2848-55. PubMed ID: 24853839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches.
    Lee SY; Allen PJ; Sadot E; D'Angelica MI; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP
    J Am Coll Surg; 2015 Jan; 220(1):18-27. PubMed ID: 25456783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection.
    Baimas-George M; Watson M; Salibi P; Tschuor C; Murphy KJ; Iannitti D; Baker E; Ocuin L; Vrochides D; Martinie JB
    Am Surg; 2021 Jan; 87(1):45-49. PubMed ID: 32915060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.